SRDX
Price:
$38.42
Market Cap:
$548.14M
Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment engages in the provision of surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices; and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device for coronary, peripheral, neuro-vascular and structural heart, and other market...[Read more]
Industry
Medical - Devices
IPO Date
1998-03-04
Stock Exchange
NASDAQ
Ticker
SRDX
According to Surmodics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 557.29M. This represents a change of 13.69% compared to the average of 490.19M of the last 4 quarters.
The mean historical Enterprise Value of Surmodics, Inc. over the last ten years is 480.83M. The current 557.29M Enterprise Value has changed 11.49% with respect to the historical average. Over the past ten years (40 quarters), SRDX's Enterprise Value was at its highest in in the September 2018 quarter at 951.10M. The Enterprise Value was at its lowest in in the March 2016 quarter at 199.77M.
Average
480.83M
Median
428.07M
Minimum
204.05M
Maximum
938.61M
Discovering the peaks and valleys of Surmodics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 139.92%
Maximum Annual Enterprise Value = 938.61M
Minimum Annual Increase = -43.85%
Minimum Annual Enterprise Value = 204.05M
Year | Enterprise Value | Change |
---|---|---|
2023 | 438.24M | 4.87% |
2022 | 417.89M | -43.85% |
2021 | 744.18M | 49.75% |
2020 | 496.96M | -14.62% |
2019 | 582.05M | -37.99% |
2018 | 938.61M | 139.92% |
2017 | 391.21M | 6.85% |
2016 | 366.12M | 59.90% |
2015 | 228.97M | 12.21% |
2014 | 204.05M | -37.88% |
The current Enterprise Value of Surmodics, Inc. (SRDX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
533.44M
5-year avg
535.86M
10-year avg
480.83M
Surmodics, Inc.’s Enterprise Value is greater than ProSomnus, Inc. Common Stock (40.81M), less than LivaNova PLC (2.97B), greater than Electromed, Inc. (166.06M), less than OrthoPediatrics Corp. (610.60M), greater than NeuroPace, Inc. (260.23M), greater than Inogen, Inc. (136.28M), greater than Pulmonx Corporation (278.28M), greater than Apyx Medical Corporation (50.19M), less than NuVasive, Inc. (2.91B), less than CONMED Corporation (2.99B), less than SI-BONE, Inc. (626.49M), less than AxoGen, Inc. (642.99M), greater than Anika Therapeutics, Inc. (335.02M), less than Orthofix Medical Inc. (711.17M), greater than Paragon 28, Inc. (555.04M), less than Integer Holdings Corporation (5.51B), greater than Sight Sciences, Inc. (209.13M),
Company | Enterprise Value | Market cap |
---|---|---|
40.81M | $8.18M | |
2.97B | $2.92B | |
166.06M | $182.05M | |
610.60M | $627.88M | |
260.23M | $199.42M | |
136.28M | $216.32M | |
278.28M | $285.81M | |
50.19M | $44.17M | |
2.91B | $2.08B | |
2.99B | $2.05B | |
626.49M | $612.07M | |
642.99M | $599.15M | |
335.02M | $369.77M | |
711.17M | $583.69M | |
555.04M | $491.23M | |
5.51B | $4.33B | |
209.13M | $292.29M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Surmodics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Surmodics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Surmodics, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Surmodics, Inc. (SRDX)?
What is the 3-year average Enterprise Value for Surmodics, Inc. (SRDX)?
What is the 5-year average Enterprise Value for Surmodics, Inc. (SRDX)?
How does the current Enterprise Value for Surmodics, Inc. (SRDX) compare to its historical average?